Get the Stockscreener App
38.48
0.29%
0.11
After Hours:
38.48
Guardian Pharmacy Services Inc stock is traded at $38.48, with a volume of 280.88K.
It is up +0.29% in the last 24 hours and up +6.12% over the past month.
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.
See More
Previous Close:
$38.37
Open:
$38.3
24h Volume:
280.88K
Relative Volume:
0.63
Market Cap:
$2.44B
Revenue:
$1.46B
Net Income/Loss:
$53.23M
P/E Ratio:
46.07
EPS:
0.8353
Net Cash Flow:
$70.01M
1W Performance:
+5.11%
1M Performance:
+6.12%
6M Performance:
+35.68%
1Y Performance:
+70.42%
1-Day Range:
$37.84
$38.93
1-Week Range:
$35.12
$38.93
52-Week Range:
$19.17
$41.36
Guardian Pharmacy Services Inc Stock (GRDN) Company Profile
Name
Guardian Pharmacy Services Inc
Sector
Industry
Phone
(404) 810-0089
Address
300 GALLERIA PARKWAY SE, ATLANTA
Compare GRDN vs HCA, THC, DVA, FMS, EHC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GRDN
Guardian Pharmacy Services Inc
|
38.48 | 2.43B | 1.46B | 53.23M | 70.01M | 0.8353 |
HCA
Hca Healthcare Inc
|
394.07 | 87.09B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
173.78 | 15.33B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
198.52 | 12.75B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
21.64 | 12.09B | 22.18B | 1.36B | 2.00B | 1.9216 |
EHC
Encompass Health Corp
|
104.96 | 10.36B | 6.07B | 793.80M | 464.40M | 5.9914 |
Guardian Pharmacy Services Inc Stock (GRDN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-27-26 | Initiated | BofA Securities | Buy |
| Mar-30-26 | Initiated | Jefferies | Buy |
| Oct-10-25 | Initiated | Oppenheimer | Outperform |
| Oct-21-24 | Initiated | Raymond James | Outperform |
| Oct-21-24 | Initiated | Truist | Buy |
Guardian Pharmacy Services Inc Stock (GRDN) Latest News
Guardian Pharmacy Services Inc. (GRDN) Q1 2026 Earnings: EPS Misses Estimates as Pharmacy Operations Face Margin PressureCrowd Sentiment Stocks - Newser
Guardian Pharmacy Services Q1 2026 Earnings: EPS Misses Estimates Amid Modest Market ResponseCommunity Watchlist Picks - Newser
Guardian Pharmacy Services Q1 2026 Earnings: EPS Miss Drags but Stock Holds SteadyInterim Report - Newser
Jeff Kerr now president at Guardian Pharmacy in Sauk Rapids - AOL.com
Guardian Pharmacy Services, Inc. names Jeff Kerr president of Sauk Rapids Pharmacy - Traders Union
Guardian Pharmacy Services Q1 earnings call highlights - MSN
Statutory Profit Doesn't Reflect How Good Guardian Pharmacy Services' (NYSE:GRDN) Earnings Are - Yahoo Finance
People in the news, May 12 - McKnight's Senior Living
Guardian Pharmacy Services : Participates in NatCon 2026 Conference - marketscreener.com
Guardian (GRDN) Q1 earnings miss by 11%, but stock holds steady amid modest investor reaction.Earnings Beat - Newser
Guardian Pharmacy Services Signals Strength Amid IRA Shock - TipRanks
Should Guardian Pharmacy’s Strong Q1 and Higher EBITDA Guidance Amid Cost Pressures Prompt Action From GRDN Investors? - Sahm
Guardian Pharmacy Services Q1 Earnings Call Highlights - MarketBeat
Guardian Pharmacy Increases Profit Targets Following Solid First Quarter - HarianBasis.co
The Bull Case For Guardian Pharmacy Services (GRDN) Could Change Following Strong Q1 Beat And New Shelf Registration - Yahoo Finance
Truist Financial Maintains Guardian Pharmacy Services(GRDN.US) With Buy Rating, Announces Target Price $43 - Moomoo
The strategic moves Guardian (GRDN) is making now (Slow Drop) 2026-05-08Community Breakout Alerts - Newser
Guardian Pharmacy Services, Inc. Class A (GRDN) Receives a Buy from Bank of America Securities - The Globe and Mail
Guardian Pharmacy Services : Andrea Silas Named President of Guardian Pharmacy of Birmingham - marketscreener.com
Guardian Pharmacy Stockholders Back Directors, Pay and Auditor - TipRanks
Guardian Pharmacy (GRDN) awards 4,028 restricted stock units to director - Stock Titan
[Form 4] Guardian Pharmacy Services, Inc. Insider Trading Activity - Stock Titan
Shareholders at Guardian Pharmacy (NYSE: GRDN) back board, pay and auditor - Stock Titan
Oppenheimer Maintains Guardian Pharmacy Services(GRDN.US) With Buy Rating, Announces Target Price $43 - 富途牛牛
Guardian Pharmacy Services, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
MSN Money - MSN
Guardian Pharmacy Services Expands Guardian One Digital Platform as CEO Fred Burke Drives Tech-Enabled Growth - InfotechLead
Guardian Pharmacy Services Q1 2026 Earnings Call Transcript - MarketBeat
Guardian Pharmacy Services (GRDN) Q1 Earnings and Revenues Surpass Estimates - Yahoo Finance
Guardian Pharmacy Services forecasts $123M-$127M adjusted EBITDA amid IRA pricing reset - MSN
Guardian Pharmacy Services Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: Guardian Pharmacy Services Q1 2026 results meet EPS expectations By Investing.com - Investing.com South Africa
Earnings call transcript: Guardian Pharmacy Services Q1 2026 results meet EPS expectations - Investing.com
Guardian Pharmacy: Q1 Earnings Snapshot - The Rome News-Tribune
Guardian Pharmacy (GRDN) readies shelf registration for Class A stock sales - Stock Titan
Guardian Pharmacy Services Announces First Quarter 2026 Results and Revises Full-Year Guidance - geneonline.com
Guardian Pharmacy (NYSE: GRDN) boosts Q1 profit on IRA-driven margin gains - Stock Titan
Guardian Pharmacy (NYSE: GRDN) lifts Q1 profit and raises 2026 EBITDA outlook - Stock Titan
Guardian Pharmacy Services Reports First Quarter 2026 Financial Results; Updates Full-Year Guidance - The Joplin Globe
Guardian says drug pricing reset hit margins, but Q1 profit still rose - Stock Titan
[SCHEDULE 13G] Guardian Pharmacy Services, Inc. Passive Investment Disclosure (>5%) - Stock Titan
Guardian (GRDN) Q1 2026 Earnings Transcript - The Globe and Mail
Jennison Associates LLC Invests $3.49 Million in Guardian Pharmacy Services, Inc. $GRDN - MarketBeat
Guardian Pharmacy Services to Report Q1 Earnings: What's in the Cards? - TradingView
Guardian Pharmacy Services Inc Stock (GRDN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.74%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):